What happens during a C&P exam for Colitis (Non-Specific)?

Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation. Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

← All Condition Guides

CLAIM RECON INTEL

Colitis (Non-Specific)

Q: What are the VA rating percentages for Colitis (Non-Specific)?

Colitis (Non-Specific) (DC 7326) is rated at 10%, 30%, 60%, 100% under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment). Minimal to mild symptomatic inflammatory bowel disease that is managed with oral or topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and no signs of systemic toxicity.

Q: What rates 10% for Colitis (Non-Specific) under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment)?

Under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment) (DC 7326), a 10% rating for Colitis (Non-Specific) requires: Minimal to mild symptomatic inflammatory bowel disease that is managed with oral or topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and no signs of systemic toxicity.

Q: What rates 30% for Colitis (Non-Specific) under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment)?

Under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment) (DC 7326), a 30% rating for Colitis (Non-Specific) requires: Mild to moderate inflammatory bowel disease that is managed with oral and topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and minimal signs of toxicity such as fever, tachycardia, or anemia.

Q: What rates 60% for Colitis (Non-Specific) under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment)?

Under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment) (DC 7326), a 60% rating for Colitis (Non-Specific) requires: Moderate inflammatory bowel disease that is managed on an outpatient basis with immunosuppressants or other biologic agents; and is characterized by recurrent abdominal pain, four to five daily episodes of diarrhea; and intermittent signs of toxicity such as fever, tachycardia, or anemia.

Q: What rates 100% for Colitis (Non-Specific) under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment)?

Under 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment) (DC 7326), a 100% rating for Colitis (Non-Specific) requires: Severe inflammatory bowel disease that is unresponsive to treatment; and requires hospitalization at least once per year; and results in either an inability to work or is characterized by recurrent abdominal pain associated with at least two of the following: (1) six or more episodes per day of diarrhea, (2) six or more episodes per day of rectal bleeding, (3) recurrent episodes of rectal incontinence, or (4) recurrent abdominal distension.

Q: What evidence do I need for a Colitis (Non-Specific) VA claim?

Key evidence for a Colitis (Non-Specific) claim includes: Service treatment records showing injury or complaints; Imaging (X-ray, MRI, CT); Range of motion measurements; Flare-up documentation per Sharp v. Shulkin; Buddy statements describing limitations. All evidence should document both the condition and its impact on daily functioning.

DC 732638 C.F.R. § 4.114

Diagnostic Code

DC 7326

38 C.F.R. § 4.114

Rating Range

10–100%

4 severity tiers

Source

Verified

38 C.F.R. § 4.114

Colitis (Non-Specific) is rated by the U.S. Department of Veterans Affairs under DC 7326 of 38 CFR § 4.114, DC 7326 (Crohn's / undifferentiated IBD framework; the former DC 7323 colitis framework was consolidated here by § 4.114 amendment) across 4 severity tiers (10% / 30% / 60% / 100%). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.

Educational tool only. Not legal or medical advice. Not affiliated with the VA.

Overview

Inflammation of the colon from various causes including infection, ischemia, or microscopic colitis

Rating Criteria

10%

Minimal to mild symptomatic inflammatory bowel disease that is managed with oral or topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and no signs of systemic toxicity.

30%

Mild to moderate inflammatory bowel disease that is managed with oral and topical agents (other than immunosuppressants or other biologic agents); and is characterized by recurrent abdominal pain with three or less daily episodes of diarrhea and minimal signs of toxicity such as fever, tachycardia, or anemia.

60%

Moderate inflammatory bowel disease that is managed on an outpatient basis with immunosuppressants or other biologic agents; and is characterized by recurrent abdominal pain, four to five daily episodes of diarrhea; and intermittent signs of toxicity such as fever, tachycardia, or anemia.

100%

Severe inflammatory bowel disease that is unresponsive to treatment; and requires hospitalization at least once per year; and results in either an inability to work or is characterized by recurrent abdominal pain associated with at least two of the following: (1) six or more episodes per day of diarrhea, (2) six or more episodes per day of rectal bleeding, (3) recurrent episodes of rectal incontinence, or (4) recurrent abdominal distension.

03Key Evidence

—Service treatment records showing injury or complaints

—Imaging (X-ray, MRI, CT)

—Range of motion measurements

—Flare-up documentation per Sharp v. Shulkin

—Buddy statements describing limitations

—Prescription history

—Physical therapy records

—Employment impact documentation

04C&P Exam Tips

1Do NOT stretch, warm up, or take pain medication before your exam. The VA needs your baseline limitation.

2Report your WORST day. DeLuca v. Brown requires documentation of functional loss during flare-ups.

3Tell the examiner about flare-ups: frequency, duration, estimated ROM loss. Sharp v. Shulkin (2017) requires estimates.

4Request active, passive, weight-bearing, and non-weight-bearing ROM testing per Correia v. McDonald (2016).

5If you use assistive devices (brace, cane), bring them.

6Describe daily activity impact: work, sleep, household tasks.

Tools

Rating Calculator →Secondaries Explorer →C&P Exam Prep →PACT Act Scanner →2026 Rates →

Sources & Editorial

Rating criteria text quoted verbatim from 38 C.F.R. § 4.114 (Digestive system). Source verified 2026-05-17 by ClaimRecon Editorial Team against the Cornell Law CFR mirror; eCFR.gov is the authoritative government source.

View § 4.114 on eCFR →Cornell Law mirror →Editorial Standards →Suggest a correction →

EDUCATIONAL TOOL ONLY. NOT LEGAL OR MEDICAL ADVICE.
NOT AFFILIATED WITH THE U.S. DEPARTMENT OF VETERANS AFFAIRS.
CLAIM RECON 2026

LOADING